{
      "Rank": 138,
      "Acronym": [
            "MSV_allo"
      ],
      "AgreementOtherDetails": [
            "The only disclosure restriction on the PI is that the sponsor must review results communications prior to public release."
      ],
      "AgreementPISponsorEmployee": [
            "No"
      ],
      "AgreementRestrictionType": [
            "OTHER"
      ],
      "AgreementRestrictiveAgreement": [
            "Yes"
      ],
      "ArmGroupDescription": [
            "Mesenchymal stem cells (MSC) prepared from bone marrow from healthy donor expanded ex vivo for 3-4 weeks. Intraarticular injection of 40 millions MSC.",
            "Intraarticular injection of hyaluronic acid (60 mg)"
      ],
      "ArmGroupInterventionName": [
            "Other: Allogenic mesenchymal stromal cells injection",
            "Drug: Hyaluronic Acid"
      ],
      "ArmGroupLabel": [
            "Allogenic mesenchymal stromal cells injection",
            "Hyaluronic acid (Durolane)"
      ],
      "ArmGroupType": [
            "Experimental",
            "Active Comparator"
      ],
      "AvailIPDComment": [],
      "AvailIPDId": [],
      "AvailIPDType": [],
      "AvailIPDURL": [],
      "BaselineCategoryTitle": [
            "Female",
            "Male",
            "American Indian or Alaska Native",
            "Asian",
            "Native Hawaiian or Other Pacific Islander",
            "Black or African American",
            "White",
            "More than one race",
            "Unknown or Not Reported"
      ],
      "BaselineClassDenomCountGroupId": [],
      "NCTId": [
            "NCT01586312"
      ],
      "BaselineClassDenomCountValue": [],
      "BaselineClassDenomUnits": [],
      "BaselineClassTitle": [
            "Spain"
      ],
      "BaselineDenomCountGroupId": [
            "BG000",
            "BG001",
            "BG002"
      ],
      "BaselineDenomCountValue": [
            "15",
            "15",
            "30"
      ],
      "BaselineDenomUnits": [
            "Participants"
      ],
      "BaselineGroupDescription": [
            "Mesenchymal stem cells (MSC) prepared from bone marrow from healthy donor expanded ex vivo for 3-4 weeks. Intraarticular injection of 40 millions MSC.\n\nInjection of Mesenchymal Stromal Cells: Mesenchymal stem cells prepared from bone marrow of healthy donors and expanded for 3-4 weeks according to our procedure described in PEI Num. 10-134, authorized by the Spanish Medicine Agency",
            "Intraarticular injection of hyaluronic acid (60 mg)\n\nHyaluronic Acid: Intra-articular injection of 60 mg of hyaluronic acid (Durolane) in a single injection (3 ml)",
            "Total of all reporting groups"
      ],
      "BaselineGroupId": [
            "BG000",
            "BG001",
            "BG002"
      ],
      "BaselineGroupTitle": [
            "Allogenic Mesenchymal Stromal Cells",
            "Hyaluronic Acid (Durolane)",
            "Total"
      ],
      "BaselineMeasureCalculatePct": [],
      "BaselineMeasureDenomCountGroupId": [],
      "BaselineMeasureDenomCountValue": [],
      "BaselineMeasureDenomUnits": [],
      "BaselineMeasureDenomUnitsSelected": [],
      "BaselineMeasureDescription": [],
      "BaselineMeasureDispersionType": [
            "Standard Deviation"
      ],
      "BaselineMeasureParamType": [
            "Mean",
            "Count of Participants",
            "Count of Participants",
            "Number"
      ],
      "BaselineMeasurePopulationDescription": [],
      "BaselineMeasureTitle": [
            "Age, Continuous",
            "Sex: Female, Male",
            "Race (NIH/OMB)",
            "Region of Enrollment"
      ],
      "BaselineMeasureUnitOfMeasure": [
            "years",
            "Participants",
            "Participants",
            "participants"
      ],
      "BaselineMeasurementComment": [],
      "BaselineMeasurementGroupId": [
            "BG000",
            "BG001",
            "BG002",
            "BG000",
            "BG001",
            "BG002",
            "BG000",
            "BG001",
            "BG002",
            "BG000",
            "BG001",
            "BG002",
            "BG000",
            "BG001",
            "BG002",
            "BG000",
            "BG001",
            "BG002",
            "BG000",
            "BG001",
            "BG002",
            "BG000",
            "BG001",
            "BG002",
            "BG000",
            "BG001",
            "BG002",
            "BG000",
            "BG001",
            "BG002",
            "BG000",
            "BG001",
            "BG002"
      ],
      "BaselineMeasurementLowerLimit": [],
      "BaselineMeasurementSpread": [
            "9.57",
            "9.41",
            "9.33"
      ],
      "BaselineMeasurementUpperLimit": [],
      "BaselineMeasurementValue": [
            "56.60",
            "57.33",
            "56.97",
            "7",
            "10",
            "17",
            "8",
            "5",
            "13",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "15",
            "15",
            "30",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "15",
            "15",
            "30"
      ],
      "BaselinePopulationDescription": [],
      "BaselineTypeUnitsAnalyzed": [],
      "BioSpecDescription": [],
      "BioSpecRetention": [],
      "BriefSummary": [
            "In this study we want to evaluate the clinical use of allogenic mesenchymal stem cells (MSC), obtained from bone marrow of healthy donors, for treatment of knee osteoarthritis. The trial is based in our own previous results with autologous MSC (ongoing NCT01183728 trial). We propose here a multicenter, phase I-II clinical trial, prospective, randomized, blinded, and controlled for the treatment of osteoarthritis (degrees II and III and IV). The assay consists of two arms with 15 patients each one. Patients in the experimental arm will be given an intra-articular transplantation of allogenic MSC, expanded \"Ex Vivo\" with our GMP-compliant procedure (MSV, PEI No. 10-134, authorized by the Competent Authority; same as in NCT01183728). In the control arm a standard treatment with intra-articular injection of hyaluronic acid shall be given. We shall follow the evolution of pain, disability, quality of life and quantitative changes in structure and composition of cartilage determined by T2-weighted MRI relaxation (Cartigram) for one year."
      ],
      "BriefTitle": [
            "Treatment of Knee Osteoarthritis With Allogenic Mesenchymal Stem Cells"
      ],
      "CentralContactEMail": [],
      "CentralContactName": [],
      "CentralContactPhone": [],
      "CentralContactPhoneExt": [],
      "CentralContactRole": [],
      "CollaboratorClass": [
            "OTHER",
            "OTHER",
            "OTHER"
      ],
      "CollaboratorName": [
            "University of Valladolid",
            "Sanidad de Castilla y Le\u00f3n",
            "Centro Medico Teknon"
      ],
      "CompletionDate": [
            "June 2014"
      ],
      "CompletionDateType": [
            "Actual"
      ],
      "Condition": [
            "Osteoarthritis, Knee",
            "Arthritis of Knee",
            "Knee Osteoarthritis"
      ],
      "ConditionAncestorId": [
            "D000001168",
            "D000007592",
            "D000009140",
            "D000012216"
      ],
      "ConditionAncestorTerm": [
            "Arthritis",
            "Joint Diseases",
            "Musculoskeletal Diseases",
            "Rheumatic Diseases"
      ],
      "ConditionBrowseBranchAbbrev": [
            "BC05",
            "All",
            "BC17"
      ],
      "ConditionBrowseBranchName": [
            "Musculoskeletal Diseases",
            "All Conditions",
            "Skin and Connective Tissue Diseases"
      ],
      "ConditionBrowseLeafAsFound": [
            "Osteoarthritis",
            "Knee Osteoarthritis"
      ],
      "ConditionBrowseLeafId": [
            "M3628",
            "M12078",
            "M21321",
            "M11249",
            "M9773",
            "M14197",
            "M5475"
      ],
      "ConditionBrowseLeafName": [
            "Arthritis",
            "Osteoarthritis",
            "Osteoarthritis, Knee",
            "Musculoskeletal Diseases",
            "Joint Diseases",
            "Rheumatic Diseases",
            "Collagen Diseases"
      ],
      "ConditionBrowseLeafRelevance": [
            "low",
            "high",
            "high",
            "low",
            "low",
            "low",
            "low"
      ],
      "ConditionMeshId": [
            "D000010003",
            "D000020370"
      ],
      "ConditionMeshTerm": [
            "Osteoarthritis",
            "Osteoarthritis, Knee"
      ],
      "DelayedPosting": [],
      "DesignAllocation": [
            "Randomized"
      ],
      "DesignInterventionModel": [
            "Parallel Assignment"
      ],
      "DesignInterventionModelDescription": [],
      "DesignMasking": [
            "Double"
      ],
      "DesignMaskingDescription": [],
      "DesignObservationalModel": [],
      "DesignPrimaryPurpose": [
            "Treatment"
      ],
      "DesignTimePerspective": [],
      "DesignWhoMasked": [
            "Participant",
            "Outcomes Assessor"
      ],
      "DetailedDescription": [],
      "DispFirstPostDate": [],
      "DispFirstPostDateType": [],
      "DispFirstSubmitDate": [],
      "DispFirstSubmitQCDate": [],
      "EligibilityCriteria": [
            "Inclusion Criteria:\n\nKnee osteoarthritis grade II, III and IV of Kellgren and Lawrence assessed by two observers.\nChronic knee pain with mechanical characteristics.\nNo local or systemic septic process.\nHaematological and biochemical analysis without significant alterations that contraindicate treatment.\nInformed written consent of the patient.\nThe patient is able to understand the nature of the study\n\nExclusion Criteria:\n\nAge over 75 or under 18 years or legally dependent\nPresent Infection (to be included in the study no signs of infection must be evidenced)\nCongenital or acquired malformation resulting in significant deformity of the knee (varus<10\u00ba; valgus<20\u00ba) and leading to problems in application or evaluation of results.\nOverweight expressed as body mass index (BMI) greater than 30.5 (obesity grade II). BMI estimated as mass (kg) / corporal surface (m2).\nWomen who are pregnant or intend to become pregnant or breast-feeding\nNeoplasia\nImmunosuppressive states\nIntra-articular infiltartion of any treatments in the last 3 months previous to study inclusion\nParticipation in another clinical trial or treatment with a different investigational product within 30 days prior to inclusion in the study.\nOther pathologic conditions or circumstances that difficult participation in the study according to medical criteria"
      ],
      "EnrollmentCount": [
            "30"
      ],
      "EnrollmentType": [
            "Actual"
      ],
      "EventGroupDeathsNumAffected": [],
      "EventGroupDeathsNumAtRisk": [],
      "EventGroupDescription": [
            "Mesenchymal stem cells (MSC) prepared from bone marrow from healthy donor expanded ex vivo for 3-4 weeks. Intraarticular injection of 40 millions MSC.\n\nInjection of Mesenchymal Stromal Cells: Mesenchymal stem cells prepared from bone marrow of healthy donors and expanded for 3-4 weeks according to our procedure described in PEI Num. 10-134, authorized by the Spanish Medicine Agency",
            "Intraarticular injection of hyaluronic acid (60 mg)\n\nHyaluronic Acid: Intra-articular injection of 60 mg of hyaluronic acid (Durolane) in a single injection (3 ml)"
      ],
      "EventGroupId": [
            "EG000",
            "EG001"
      ],
      "EventGroupOtherNumAffected": [
            "14",
            "13"
      ],
      "EventGroupOtherNumAtRisk": [
            "15",
            "15"
      ],
      "EventGroupSeriousNumAffected": [
            "0",
            "0"
      ],
      "EventGroupSeriousNumAtRisk": [
            "15",
            "15"
      ],
      "EventGroupTitle": [
            "Allogenic Mesenchymal Stromal Cells",
            "Hyaluronic Acid (Durolane)"
      ],
      "EventsDescription": [
            "All patients completed the study successfully. The mean duration of the patients in the study was 12.4 (\u00b1 0.6) months, 12.5 (\u00b1 0.8) months in the MSV group and 12.4 (\u00b1 0.3) months in the hyaluronic acid group."
      ],
      "EventsFrequencyThreshold": [
            "0"
      ],
      "EventsTimeFrame": [
            "1 year"
      ],
      "ExpAccTypeIndividual": [],
      "ExpAccTypeIntermediate": [],
      "ExpAccTypeTreatment": [],
      "ExpandedAccessNCTId": [],
      "ExpandedAccessStatusForNCTId": [],
      "FDAAA801Violation": [],
      "FlowAchievementComment": [],
      "FlowAchievementGroupId": [
            "FG000",
            "FG001",
            "FG000",
            "FG001",
            "FG000",
            "FG001"
      ],
      "FlowAchievementNumSubjects": [
            "15",
            "15",
            "15",
            "15",
            "0",
            "0"
      ],
      "FlowAchievementNumUnits": [],
      "FlowDropWithdrawComment": [],
      "FlowDropWithdrawType": [],
      "FlowGroupDescription": [
            "Mesenchymal stem cells (MSC) prepared from bone marrow from healthy donor expanded ex vivo for 3-4 weeks. Intraarticular injection of 40 millions MSC.\n\nInjection of Mesenchymal Stromal Cells: Mesenchymal stem cells prepared from bone marrow of healthy donors and expanded for 3-4 weeks according to our procedure described in PEI Num. 10-134, authorized by the Spanish Medicine Agency",
            "Intraarticular injection of hyaluronic acid (60 mg)\n\nHyaluronic Acid: Intra-articular injection of 60 mg of hyaluronic acid (Durolane) in a single injection (3 ml)"
      ],
      "FlowGroupId": [
            "FG000",
            "FG001"
      ],
      "FlowGroupTitle": [
            "Allogenic Mesenchymal Stromal Cells",
            "Hyaluronic Acid (Durolane)"
      ],
      "FlowMilestoneComment": [],
      "FlowMilestoneType": [
            "STARTED",
            "COMPLETED",
            "NOT COMPLETED"
      ],
      "FlowPeriodTitle": [
            "Overall Study"
      ],
      "FlowPreAssignmentDetails": [
            "All patients fulfilled the selection criteria, were randomized and received the assigned medication."
      ],
      "FlowReasonComment": [],
      "FlowReasonGroupId": [],
      "FlowReasonNumSubjects": [],
      "FlowReasonNumUnits": [],
      "FlowRecruitmentDetails": [
            "30 patients were included between 26/Jul/2012 (Pat. 01) and12/Dic/2012 (Pat. 30)."
      ],
      "FlowTypeUnitsAnalyzed": [],
      "Gender": [
            "All"
      ],
      "GenderBased": [],
      "GenderDescription": [],
      "HasExpandedAccess": [
            "No"
      ],
      "HealthyVolunteers": [
            "No"
      ],
      "IPDSharing": [],
      "IPDSharingAccessCriteria": [],
      "IPDSharingDescription": [],
      "IPDSharingInfoType": [],
      "IPDSharingTimeFrame": [],
      "IPDSharingURL": [],
      "InterventionAncestorId": [
            "D000000276",
            "D000007155",
            "D000045505",
            "D000055675",
            "D000020011"
      ],
      "InterventionAncestorTerm": [
            "Adjuvants, Immunologic",
            "Immunologic Factors",
            "Physiological Effects of Drugs",
            "Viscosupplements",
            "Protective Agents"
      ],
      "InterventionArmGroupLabel": [
            "Allogenic mesenchymal stromal cells injection",
            "Hyaluronic acid (Durolane)"
      ],
      "InterventionBrowseBranchAbbrev": [
            "All"
      ],
      "InterventionBrowseBranchName": [
            "All Drugs and Chemicals"
      ],
      "InterventionBrowseLeafAsFound": [
            "Compression"
      ],
      "InterventionBrowseLeafId": [
            "M9030",
            "M2780",
            "M9353",
            "M27448",
            "M21022"
      ],
      "InterventionBrowseLeafName": [
            "Hyaluronic Acid",
            "Adjuvants, Immunologic",
            "Immunologic Factors",
            "Viscosupplements",
            "Protective Agents"
      ],
      "InterventionBrowseLeafRelevance": [
            "high",
            "low",
            "low",
            "low",
            "low"
      ],
      "InterventionDescription": [
            "Mesenchymal stem cells prepared from bone marrow of healthy donors and expanded for 3-4 weeks according to our procedure described in PEI Num. 10-134, authorized by the Spanish Medicine Agency",
            "Intra-articular injection of 60 mg of hyaluronic acid (Durolane) in a single injection (3 ml)"
      ],
      "InterventionMeshId": [
            "D000006820"
      ],
      "InterventionMeshTerm": [
            "Hyaluronic Acid"
      ],
      "InterventionName": [
            "Allogenic mesenchymal stromal cells injection",
            "Hyaluronic Acid"
      ],
      "InterventionOtherName": [
            "MSV",
            "Mesenchymal Stem Cells",
            "MSC",
            "Hyaluronic acid, durolane, CE mark:516407"
      ],
      "InterventionType": [
            "Other",
            "Drug"
      ],
      "IsFDARegulatedDevice": [],
      "IsFDARegulatedDrug": [],
      "IsPPSD": [],
      "IsUSExport": [],
      "IsUnapprovedDevice": [],
      "Keyword": [
            "Knee degenerative disease",
            "osteoarthritis",
            "gonarthrosis",
            "stem cell",
            "cellular therapy",
            "regenerative therapy",
            "Mesenchymal stem cells",
            "Bone marrow",
            "musculoskeletal Diseases",
            "Mesenchymal Stromal Cells (allogenic)"
      ],
      "LargeDocDate": [],
      "LargeDocFilename": [],
      "LargeDocHasICF": [],
      "LargeDocHasProtocol": [],
      "LargeDocHasSAP": [],
      "LargeDocLabel": [],
      "LargeDocTypeAbbrev": [],
      "LargeDocUploadDate": [],
      "LastKnownStatus": [],
      "LastUpdatePostDate": [
            "October 16, 2015"
      ],
      "LastUpdatePostDateType": [
            "Estimate"
      ],
      "LastUpdateSubmitDate": [
            "September 26, 2015"
      ],
      "LeadSponsorClass": [
            "INDUSTRY"
      ],
      "LeadSponsorName": [
            "Red de Terapia Celular"
      ],
      "LimitationsAndCaveatsDescription": [],
      "LocationCity": [
            "Barcelona",
            "Valladolid"
      ],
      "LocationContactEMail": [],
      "LocationContactName": [],
      "LocationContactPhone": [],
      "LocationContactPhoneExt": [],
      "LocationContactRole": [],
      "LocationCountry": [
            "Spain",
            "Spain"
      ],
      "LocationFacility": [
            "Centro Medico Teknon",
            "Hospital Clinico Universitario"
      ],
      "LocationState": [],
      "LocationStatus": [],
      "LocationZip": [
            "08022",
            "47003"
      ],
      "MaximumAge": [
            "75 Years"
      ],
      "MinimumAge": [
            "18 Years"
      ],
      "NCTIdAlias": [],
      "OfficialTitle": [
            "Treatment of Knee Osteoarthritis With Allogenic Mesenchymal Stem Cells (MSV*) *MSV: Mesenchymal Stromal Cells From Valladolid"
      ],
      "OrgClass": [
            "INDUSTRY"
      ],
      "OrgFullName": [
            "Red de Terapia Celular"
      ],
      "OrgStudyId": [
            "TerCel004"
      ],
      "OrgStudyIdDomain": [],
      "OrgStudyIdLink": [],
      "OrgStudyIdType": [],
      "OtherEventAssessmentType": [
            "Systematic Assessment",
            "Systematic Assessment",
            "Systematic Assessment",
            "Systematic Assessment",
            "Systematic Assessment",
            "Systematic Assessment",
            "Systematic Assessment",
            "Systematic Assessment",
            "Systematic Assessment",
            "Systematic Assessment",
            "Systematic Assessment",
            "Systematic Assessment",
            "Systematic Assessment",
            "Systematic Assessment",
            "Systematic Assessment",
            "Systematic Assessment",
            "Systematic Assessment",
            "Systematic Assessment",
            "Systematic Assessment",
            "Systematic Assessment",
            "Systematic Assessment",
            "Systematic Assessment",
            "Systematic Assessment",
            "Systematic Assessment",
            "Systematic Assessment",
            "Systematic Assessment",
            "Systematic Assessment",
            "Systematic Assessment",
            "Systematic Assessment"
      ],
      "OtherEventNotes": [],
      "OtherEventOrganSystem": [
            "Musculoskeletal and connective tissue disorders",
            "Musculoskeletal and connective tissue disorders",
            "Musculoskeletal and connective tissue disorders",
            "Musculoskeletal and connective tissue disorders",
            "Infections and infestations",
            "Infections and infestations",
            "Infections and infestations",
            "Infections and infestations",
            "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
            "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
            "Surgical and medical procedures",
            "Skin and subcutaneous tissue disorders",
            "Reproductive system and breast disorders",
            "Reproductive system and breast disorders",
            "Reproductive system and breast disorders",
            "Reproductive system and breast disorders",
            "Immune system disorders",
            "Nervous system disorders",
            "Nervous system disorders",
            "Nervous system disorders",
            "Endocrine disorders",
            "Gastrointestinal disorders",
            "General disorders",
            "Musculoskeletal and connective tissue disorders",
            "Musculoskeletal and connective tissue disorders",
            "Eye disorders",
            "Psychiatric disorders",
            "Psychiatric disorders",
            "Vascular disorders"
      ],
      "OtherEventSourceVocabulary": [
            "MedDRA v16.0",
            "MedDRA v16.0",
            "MedDRA v16.0",
            "MedDRA v16.0",
            "MedDRA v16.0",
            "MedDRA v16.0",
            "MedDRA v16.0",
            "MedDRA v16.0",
            "MedDRA v16.0",
            "MedDRA v16.0",
            "MedDRA v16.0",
            "MedDRA v16.0",
            "MedDRA v16.0",
            "MedDRA v16.0",
            "MedDRA v16.0",
            "MedDRA v16.0",
            "MedDRA v16.0",
            "MedDRA v16.0",
            "MedDRA v16.0",
            "MedDRA v16.0",
            "MedDRA v16.0",
            "MedDRA v16.0",
            "MedDRA v16.0",
            "MedDRA v16.0",
            "MedDRA v16.0",
            "MedDRA v16.0",
            "MedDRA v16.0",
            "MedDRA v16.0",
            "MedDRA v16.0"
      ],
      "OtherEventStatsGroupId": [
            "EG000",
            "EG001",
            "EG000",
            "EG001",
            "EG000",
            "EG001",
            "EG000",
            "EG001",
            "EG000",
            "EG001",
            "EG000",
            "EG001",
            "EG000",
            "EG001",
            "EG000",
            "EG001",
            "EG000",
            "EG001",
            "EG000",
            "EG001",
            "EG000",
            "EG001",
            "EG000",
            "EG001",
            "EG000",
            "EG001",
            "EG000",
            "EG001",
            "EG000",
            "EG001",
            "EG000",
            "EG001",
            "EG000",
            "EG001",
            "EG000",
            "EG001",
            "EG000",
            "EG001",
            "EG000",
            "EG001",
            "EG000",
            "EG001",
            "EG000",
            "EG001",
            "EG000",
            "EG001",
            "EG000",
            "EG001",
            "EG000",
            "EG001",
            "EG000",
            "EG001",
            "EG000",
            "EG001",
            "EG000",
            "EG001",
            "EG000",
            "EG001"
      ],
      "OtherEventStatsNumAffected": [
            "6",
            "7",
            "2",
            "3",
            "2",
            "2",
            "0",
            "1",
            "3",
            "2",
            "1",
            "0",
            "1",
            "1",
            "1",
            "0",
            "0",
            "1",
            "0",
            "1",
            "0",
            "2",
            "0",
            "1",
            "1",
            "0",
            "0",
            "1",
            "1",
            "0",
            "0",
            "1",
            "2",
            "0",
            "1",
            "2",
            "0",
            "1",
            "1",
            "0",
            "0",
            "1",
            "0",
            "2",
            "1",
            "0",
            "3",
            "1",
            "0",
            "1",
            "0",
            "1",
            "1",
            "0",
            "0",
            "1",
            "0",
            "1"
      ],
      "OtherEventStatsNumAtRisk": [
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15",
            "15"
      ],
      "OtherEventStatsNumEvents": [
            "9",
            "9",
            "3",
            "4",
            "2",
            "2",
            "0",
            "1",
            "3",
            "3",
            "1",
            "0",
            "1",
            "2",
            "1",
            "0",
            "0",
            "1",
            "0",
            "1",
            "0",
            "2",
            "0",
            "1",
            "1",
            "0",
            "0",
            "1",
            "1",
            "0",
            "0",
            "2",
            "2",
            "0",
            "1",
            "12",
            "0",
            "1",
            "1",
            "0",
            "0",
            "1",
            "0",
            "2",
            "1",
            "0",
            "3",
            "1",
            "0",
            "1",
            "0",
            "1",
            "1",
            "0",
            "0",
            "1",
            "0",
            "1"
      ],
      "OtherEventTerm": [
            "Artralgia",
            "Joint Effusion",
            "Back pain",
            "Musculoskeletal pain",
            "Ear infection",
            "Nasofaringitis",
            "Pneumonia",
            "Rinitis",
            "Basal cell carcinoma",
            "Neoplasia",
            "Dental implant",
            "Allergic dermatitis",
            "Amenorrhea",
            "Testicular pain",
            "Premature menopause",
            "Menorrhagia",
            "Hypersensitivity",
            "Amnesia",
            "Migraine",
            "Drowsiness",
            "Hyperthyroidism",
            "Dental pain",
            "Leak",
            "Artralgia/Artritis",
            "Arthralgia/Effusion",
            "Corneal erosion / Blepharitis",
            "Depression",
            "Nervousness",
            "Hypertension"
      ],
      "OtherOutcomeDescription": [],
      "OtherOutcomeMeasure": [],
      "OtherOutcomeTimeFrame": [],
      "OutcomeAnalysisCILowerLimit": [],
      "OutcomeAnalysisCILowerLimitComment": [],
      "OutcomeAnalysisCINumSides": [],
      "OutcomeAnalysisCIPctValue": [],
      "OutcomeAnalysisCIUpperLimit": [],
      "OutcomeAnalysisCIUpperLimitComment": [],
      "OutcomeAnalysisDispersionType": [],
      "OutcomeAnalysisDispersionValue": [],
      "OutcomeAnalysisEstimateComment": [],
      "OutcomeAnalysisGroupDescription": [],
      "OutcomeAnalysisGroupId": [],
      "OutcomeAnalysisNonInferiorityComment": [],
      "OutcomeAnalysisNonInferiorityType": [],
      "OutcomeAnalysisOtherAnalysisDescription": [],
      "OutcomeAnalysisPValue": [],
      "OutcomeAnalysisPValueComment": [],
      "OutcomeAnalysisParamType": [],
      "OutcomeAnalysisParamValue": [],
      "OutcomeAnalysisStatisticalComment": [],
      "OutcomeAnalysisStatisticalMethod": [],
      "OutcomeAnalysisTestedNonInferiority": [],
      "OutcomeCategoryTitle": [],
      "OutcomeClassDenomCountGroupId": [],
      "OutcomeClassDenomCountValue": [],
      "OutcomeClassDenomUnits": [],
      "OutcomeClassTitle": [
            "WOMAC11_Changes from Basal - General 3 months",
            "WOMAC11_Changes from Basal - General 6 months",
            "WOMAC11_Changes from Basal - General 12 months",
            "WOMAC11_Changes from Basal - Dificulty 3 months",
            "WOMAC11_Changes from Basal - Dificulty 6 months",
            "WOMAC11_Changes from Basal - Dificulty 12 months",
            "WOMAC11_Changes from Basal - Stiffness 3 months",
            "WOMAC11_Changes from Basal - Stiffness 6 months",
            "WOMAC11_Changes from Basal - Stiffness 12 months",
            "WOMAC11_Changes from Basal - Pain 3 months",
            "WOMAC11_Changes from Basal - Pain 6 months",
            "WOMAC11_Changes from Basal - Pain 12 months",
            "SF-12_Changes from Basal - General Health 3 months",
            "SF-12_Changes from Basal - General Health 6 months",
            "SF-12_Changes from Basal - General Health 12 month",
            "SF-12_Changes from Basal - Physical function 3 m",
            "SF-12_Changes from Basal - Physical function 6 m",
            "SF-12_Changes from Basal - Physical function 12 m",
            "SF-12_Changes from Basal - Physical rol 3 months",
            "SF-12_Changes from Basal - Physical rol 6 months",
            "SF-12_Changes from Basal - Physical rol 12 months",
            "SF-12_Changes from Basal - Emotional rol 3 months",
            "SF-12_Changes from Basal - Emotional rol 6 months",
            "SF-12_Changes from Basal - Emotional rol 12 months",
            "SF-12_Changes from Basal - Body pain 3 months",
            "SF-12_Changes from Basal - Body pain 6 months",
            "SF-12_Changes from Basal - Body pain 12 months",
            "SF-12_Changes from Basal - Mental Health 3 months",
            "SF-12_Changes from Basal - Mental Health 6 months",
            "SF-12_Changes from Basal - Mental Health 12 months",
            "SF-12_Changes from Basal - Vitality 3 months",
            "SF-12_Changes from Basal - Vitality 6 months",
            "SF-12_Changes from Basal - Vitality 12 months",
            "SF-12_Changes from Basal - Social function 3 mo",
            "SF-12_Changes from Basal - Social function 6 mo",
            "SF-12_Changes from Basal - Social function 12 mo",
            "SF-12_Changes from Basal - Physical Health 3 mo",
            "SF-12_Changes from Basal - Physical Health 6 mo",
            "SF-12_Changes from Basal - Physical Health 12 mo",
            "SF-12_Changes from Basal - Mental Health 3 mo",
            "SF-12_Changes from Basal - Mental Health 6 mo",
            "SF-12_Changes from Basal - Mental Health 12 mo",
            "VAS_Changes from Basal - 3 months",
            "VAS_Changes from Basal - 6 months",
            "VAS_Changes from Basal - 12 months",
            "LEQUESNE_Changes from Basal - 3 months",
            "LEQUESNE_Changes from Basal - 6 months",
            "LEQUESNE_Changes from Basal - 12 months",
            "MRI. N\u00ba of values between 50-90 per visit. 0",
            "MRI. N\u00ba of values between 50-90 per visit. 6",
            "MRI.N\u00ba of values between 50-90 per visit.12.",
            "MRI. Change of N\u00ba of measurements. 6",
            "MRI. Change of N\u00ba of measurements.12"
      ],
      "OutcomeDenomCountGroupId": [
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001"
      ],
      "OutcomeDenomCountValue": [
            "15",
            "15",
            "15",
            "15",
            "12",
            "15"
      ],
      "OutcomeDenomUnits": [
            "Participants",
            "Participants",
            "Participants"
      ],
      "OutcomeGroupDescription": [
            "Mesenchymal stem cells (MSC) prepared from bone marrow from healthy donor expanded ex vivo for 3-4 weeks. Intraarticular injection of 40 millions MSC.\n\nInjection of Mesenchymal Stromal Cells: Mesenchymal stem cells prepared from bone marrow of healthy donors and expanded for 3-4 weeks according to our procedure described in PEI Num. 10-134, authorized by the Spanish Medicine Agency",
            "Intraarticular injection of hyaluronic acid (60 mg)\n\nHyaluronic Acid: Intra-articular injection of 60 mg of hyaluronic acid (Durolane) in a single injection (3 ml)",
            "Mesenchymal stem cells (MSC) prepared from bone marrow from healthy donor expanded ex vivo for 3-4 weeks. Intraarticular injection of 40 millions MSC.\n\nInjection of Mesenchymal Stromal Cells: Mesenchymal stem cells prepared from bone marrow of healthy donors and expanded for 3-4 weeks according to our procedure described in PEI Num. 10-134, authorized by the Spanish Medicine Agency",
            "Intraarticular injection of hyaluronic acid (60 mg)\n\nHyaluronic Acid: Intra-articular injection of 60 mg of hyaluronic acid (Durolane) in a single injection (3 ml)",
            "Mesenchymal stem cells (MSC) prepared from bone marrow from healthy donor expanded ex vivo for 3-4 weeks. Intraarticular injection of 40 millions MSC.\n\nInjection of Mesenchymal Stromal Cells: Mesenchymal stem cells prepared from bone marrow of healthy donors and expanded for 3-4 weeks according to our procedure described in PEI Num. 10-134, authorized by the Spanish Medicine Agency",
            "Intraarticular injection of hyaluronic acid (60 mg)\n\nHyaluronic Acid: Intra-articular injection of 60 mg of hyaluronic acid (Durolane) in a single injection (3 ml)"
      ],
      "OutcomeGroupId": [
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001"
      ],
      "OutcomeGroupTitle": [
            "Allogenic Mesenchymal Stromal Cells",
            "Hyaluronic Acid (Durolane)",
            "Allogenic Mesenchymal Stromal Cells",
            "Hyaluronic Acid (Durolane)",
            "Allogenic Mesenchymal Stromal Cells",
            "Hyaluronic Acid (Durolane)"
      ],
      "OutcomeMeasureAnticipatedPostingDate": [],
      "OutcomeMeasureCalculatePct": [],
      "OutcomeMeasureDenomUnitsSelected": [],
      "OutcomeMeasureDescription": [
            "Adverse events reported. Clinical review and questionaires for pain, disability and quality of life at 0, 3, 6 and 12 months",
            "Clinical review, questionaires for pain, disability and quality of life at 0, 3, 6 and 12 months.\n\nWOMAC (Western Ontario and McMaster Universities Osteoarthritis Index): Questionnaire to quantify the pain, stiffness and physical function in patients with osteoarthritis of the knee or hip.\n\nSF-12 (Short Form 12, an abbreviated form of SF36) is a questionnaire for the detection of changes in quality of life.\n\nThe visual analogue scale (VAS) is a psychometric response scale which can be used for subjective measurements of knee pain.\n\nLEQUESNE algofunctional index: is a composite measure of pain and disability, with specific self-report questionnaires for knee (osteoarthritis).\n\nAll the scale ranges ranges (minimum and maximum scores) are between 0 and 100%.\n\nValues are given in differences from baseline (usually negative values). More negative values show more improvement on both scales.",
            "Magnetic Resonance imaging measurements of T2 relaxation (Cartigram) performed at 0, 6 and 12 months to quantify articular cartilage degeneration. The values (in milliseconds) are T1/2 for decay of the T2 MRI signals. Normal values are below 50 ms; values above 50 ms correspond to inflamed cartilage.\n\nMean (SD) are expressed as the number of values (of a total of 88 measurements) that are between 50 and 90 ms. A value =<4.4 is considered normal (can be attained by chance). Values above 4.4 are considered pathological. The worst possible is 88."
      ],
      "OutcomeMeasureDispersionType": [
            "Standard Deviation",
            "Standard Deviation"
      ],
      "OutcomeMeasureParamType": [
            "Number",
            "Mean",
            "Mean"
      ],
      "OutcomeMeasurePopulationDescription": [
            "Efficacy evaluable patients (EEP): A patient has been considered evaluable whenever it has undergone the specified interventions (injection of hyaluronic acid or allogeneic MSC).\n\nand\n\nSafety population (SP): The population that includes all evaluable patients who have undergone one of the two study treatments.",
            "The efficacy endpoint analysis will be based on all patients who have not committed major protocol violations, and have at least one assessment of efficacy of the end graft. 3 patients of the allogenic MSC treatment group were excluded from this analysis because of incomplete measurements."
      ],
      "OutcomeMeasureReportingStatus": [
            "Posted",
            "Posted",
            "Posted"
      ],
      "OutcomeMeasureTimeFrame": [
            "Up to one year",
            "up to one year",
            "up to one year"
      ],
      "OutcomeMeasureTitle": [
            "Number of Participants With Adverse Events as a Measure of Safety and Tolerability",
            "Pain and Disability Evolution (WOMAC, Visual Analogue Scale, Lequesne Index and SF-12 Scores)",
            "Evolution of Cartilage Degeneration by T2 Relaxation Measurements in MRI (Cartigram)"
      ],
      "OutcomeMeasureType": [
            "Primary",
            "Secondary",
            "Secondary"
      ],
      "OutcomeMeasureTypeUnitsAnalyzed": [],
      "OutcomeMeasureUnitOfMeasure": [
            "participants",
            "units on a scale",
            "number of values (range 0-88)"
      ],
      "OutcomeMeasurementComment": [],
      "OutcomeMeasurementGroupId": [
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001",
            "OG000",
            "OG001"
      ],
      "OutcomeMeasurementLowerLimit": [],
      "OutcomeMeasurementSpread": [
            "22.6",
            "17.4",
            "18.2",
            "15.9",
            "22.8",
            "18.4",
            "22.8",
            "18.7",
            "19.8",
            "20.5",
            "23.1",
            "21.3",
            "30.5",
            "25.2",
            "23.8",
            "23.6",
            "31.1",
            "29.5",
            "23.7",
            "17.2",
            "19.0",
            "12.1",
            "23",
            "15.8",
            "22.5",
            "16.2",
            "22.8",
            "21.2",
            "27.9",
            "21.1",
            "36.4",
            "30.6",
            "26.5",
            "32.6",
            "22.9",
            "30.2",
            "21.2",
            "31.2",
            "38.9",
            "29.7",
            "34.0",
            "30.6",
            "22.6",
            "24.5",
            "33.0",
            "15.6",
            "31.0",
            "18.0",
            "26.4",
            "28.7",
            "28.0",
            "26.5",
            "36.4",
            "24.8",
            "24.5",
            "19.7",
            "25.2",
            "19.7",
            "14.2",
            "18.8",
            "37.2",
            "25.8",
            "33.4",
            "25.8",
            "36.2",
            "24.0",
            "27.5",
            "27.5",
            "27.5",
            "29.1",
            "29.1",
            "26.7",
            "7.8",
            "7.6",
            "7.0",
            "9.3",
            "9.3",
            "9.3",
            "10.5",
            "8.9",
            "11.7",
            "7.0",
            "8.2",
            "9.1",
            "30.7",
            "23.6",
            "29.3",
            "20.6",
            "28.5",
            "21.6",
            "12.4",
            "12.8",
            "10.8",
            "13.4",
            "12.4",
            "12.6",
            "3.5",
            "5.7",
            "4.5",
            "7.5",
            "5.6",
            "5.5",
            "2.5",
            "5.8",
            "6.0",
            "4.1"
      ],
      "OutcomeMeasurementUpperLimit": [],
      "OutcomeMeasurementValue": [
            "14",
            "13",
            "-8.48",
            "-4.52",
            "-13.03",
            "-5.47",
            "-13.47",
            "-4.10",
            "-8.51",
            "-6.46",
            "-14.53",
            "-6.97",
            "-12.59",
            "-4.26",
            "-4.77",
            "-1.93",
            "-3.17",
            "-2.87",
            "-10.67",
            "-4.50",
            "-10.01",
            "-4.27",
            "-13.02",
            "-5.97",
            "-16.30",
            "-6.36",
            "0.12",
            "0.39",
            "10.64",
            "2.11",
            "5.24",
            "2.51",
            "10.00",
            "18.33",
            "13.33",
            "11.67",
            "21.67",
            "20.00",
            "2.50",
            "4.17",
            "6.67",
            "9.17",
            "5.00",
            "6.67",
            "-1.67",
            "-5.83",
            "5.83",
            "1.67",
            "0.00",
            "0.83",
            "10.0",
            "5.00",
            "15.00",
            "11.67",
            "13.33",
            "13.33",
            "-5.83",
            "3.33",
            "3.33",
            "3.33",
            "0.00",
            "5.00",
            "-6.67",
            "1.67",
            "-1.67",
            "1.67",
            "-8.33",
            "-6.67",
            "-1.67",
            "-1.67",
            "6.67",
            "-6.67",
            "6.67",
            "0.00",
            "3.44",
            "3.71",
            "4.51",
            "3.76",
            "5.42",
            "4.59",
            "-3.56",
            "-1.99",
            "0.44",
            "-1.09",
            "-2.41",
            "-1.56",
            "-13.67",
            "-7.53",
            "-20.67",
            "-11.93",
            "-21.20",
            "-13.07",
            "-3.63",
            "-5.18",
            "-13.95",
            "-5.46",
            "-8.76",
            "-3.13",
            "12.33",
            "13.53",
            "9.33",
            "11.73",
            "8.25",
            "10.73",
            "-3.00",
            "-1.80",
            "-4.08",
            "-2.80"
      ],
      "OverallOfficialAffiliation": [
            "University of Valladolid, Scientific Park",
            "Hospital Clinico Universitario, Valladolid",
            "Centro M\u00e9dico Teknon, Barcelona",
            "Director, Cell Production Unit, Parque Cient\u00edfico UVa",
            "Virgen de la Arrixaca University Hospital, Murcia, Spain"
      ],
      "OverallOfficialName": [
            "Javier Garc\u00eda-Sancho, MD, PhD",
            "Aurelio Vega, MD,PhD",
            "Luis Orozco, MD, PhD",
            "Ana Sanchez, MD, PhD",
            "Jose M Moraleda, MD. PhD"
      ],
      "OverallOfficialRole": [
            "Study Chair",
            "Study Director",
            "Study Director",
            "Study Director",
            "Study Director"
      ],
      "OverallStatus": [
            "Completed"
      ],
      "OversightHasDMC": [
            "Yes"
      ],
      "PatientRegistry": [],
      "Phase": [
            "Phase 1",
            "Phase 2"
      ],
      "PointOfContactEMail": [
            "jgsancho@ibgm.uva.es"
      ],
      "PointOfContactOrganization": [
            "Instituto de Biolog\u00eda y Gen\u00e9tica Molecular (IBGM)"
      ],
      "PointOfContactPhone": [
            "34 983 423 084"
      ],
      "PointOfContactPhoneExt": [],
      "PointOfContactTitle": [
            "Professor Javier Garcia-Sancho"
      ],
      "PrimaryCompletionDate": [
            "December 2013"
      ],
      "PrimaryCompletionDateType": [
            "Actual"
      ],
      "PrimaryOutcomeDescription": [
            "Adverse events reported. Clinical review and questionaires for pain, disability and quality of life at 0, 3, 6 and 12 months"
      ],
      "PrimaryOutcomeMeasure": [
            "Number of Participants With Adverse Events as a Measure of Safety and Tolerability"
      ],
      "PrimaryOutcomeTimeFrame": [
            "Up to one year"
      ],
      "ReferenceCitation": [
            "Orozco L, Soler R, Morera C, Alberca M, S\u00e1nchez A, Garc\u00eda-Sancho J. Intervertebral disc repair by autologous mesenchymal bone marrow cells: a pilot study. Transplantation. 2011 Oct 15;92(7):822-8. doi: 10.1097/TP.0b013e3182298a15.",
            "Orozco L, Munar A, Soler R, Alberca M, Soler F, Huguet M, Sent\u00eds J, S\u00e1nchez A, Garc\u00eda-Sancho J. Treatment of knee osteoarthritis with autologous mesenchymal stem cells: a pilot study. Transplantation. 2013 Jun 27;95(12):1535-41. doi: 10.1097/TP.0b013e318291a2da.",
            "Orozco L, Munar A, Soler R, Alberca M, Soler F, Huguet M, Sent\u00eds J, S\u00e1nchez A, Garc\u00eda-Sancho J. Treatment of knee osteoarthritis with autologous mesenchymal stem cells: two-year follow-up results. Transplantation. 2014 Jun 15;97(11):e66-8. doi: 10.1097/TP.0000000000000167.",
            "Vega A, Mart\u00edn-Ferrero MA, Del Canto F, Alberca M, Garc\u00eda V, Munar A, Orozco L, Soler R, Fuertes JJ, Huguet M, S\u00e1nchez A, Garc\u00eda-Sancho J. Treatment of Knee Osteoarthritis With Allogeneic Bone Marrow Mesenchymal Stem Cells: A Randomized Controlled Trial. Transplantation. 2015 Aug;99(8):1681-90. doi: 10.1097/TP.0000000000000678."
      ],
      "ReferencePMID": [
            "21792091",
            "23680930",
            "24887752",
            "25822648"
      ],
      "ReferenceType": [
            "background",
            "background",
            "background",
            "derived"
      ],
      "RemovedCountry": [],
      "ResponsiblePartyInvestigatorAffiliation": [],
      "ResponsiblePartyInvestigatorFullName": [],
      "ResponsiblePartyInvestigatorTitle": [],
      "ResponsiblePartyOldNameTitle": [],
      "ResponsiblePartyOldOrganization": [],
      "ResponsiblePartyType": [
            "Sponsor"
      ],
      "ResultsFirstPostDate": [
            "November 6, 2014"
      ],
      "ResultsFirstPostDateType": [
            "Estimate"
      ],
      "ResultsFirstPostedQCCommentsDate": [],
      "ResultsFirstPostedQCCommentsDateType": [],
      "ResultsFirstSubmitDate": [
            "September 24, 2014"
      ],
      "ResultsFirstSubmitQCDate": [
            "November 4, 2014"
      ],
      "RetractionPMID": [],
      "RetractionSource": [],
      "SamplingMethod": [],
      "SecondaryId": [
            "2011-005321-51",
            "EC11-309",
            "MSV_allo"
      ],
      "SecondaryIdDomain": [
            "Spanish Ministry of Health, Independent Clinical Investigatio",
            "Protocol code"
      ],
      "SecondaryIdLink": [],
      "SecondaryIdType": [
            "EudraCT Number",
            "Other Grant/Funding Number",
            "Registry Identifier"
      ],
      "SecondaryOutcomeDescription": [
            "Clinical review, questionaires for pain, disability and quality of life at 0, 3, 6 and 12 months.\n\nWOMAC (Western Ontario and McMaster Universities Osteoarthritis Index): Questionnaire to quantify the pain, stiffness and physical function in patients with osteoarthritis of the knee or hip.\n\nSF-12 (Short Form 12, an abbreviated form of SF36) is a questionnaire for the detection of changes in quality of life.\n\nThe visual analogue scale (VAS) is a psychometric response scale which can be used for subjective measurements of knee pain.\n\nLEQUESNE algofunctional index: is a composite measure of pain and disability, with specific self-report questionnaires for knee (osteoarthritis).\n\nAll the scale ranges ranges (minimum and maximum scores) are between 0 and 100%.\n\nValues are given in differences from baseline (usually negative values). More negative values show more improvement on both scales.",
            "Magnetic Resonance imaging measurements of T2 relaxation (Cartigram) performed at 0, 6 and 12 months to quantify articular cartilage degeneration. The values (in milliseconds) are T1/2 for decay of the T2 MRI signals. Normal values are below 50 ms; values above 50 ms correspond to inflamed cartilage.\n\nMean (SD) are expressed as the number of values (of a total of 88 measurements) that are between 50 and 90 ms. A value =<4.4 is considered normal (can be attained by chance). Values above 4.4 are considered pathological. The worst possible is 88."
      ],
      "SecondaryOutcomeMeasure": [
            "Pain and Disability Evolution (WOMAC, Visual Analogue Scale, Lequesne Index and SF-12 Scores)",
            "Evolution of Cartilage Degeneration by T2 Relaxation Measurements in MRI (Cartigram)"
      ],
      "SecondaryOutcomeTimeFrame": [
            "up to one year",
            "up to one year"
      ],
      "SeeAlsoLinkLabel": [
            "Cell Therapy Network",
            "MSV providing",
            "osteoarthritis, knee",
            "mesenchymal stem cells"
      ],
      "SeeAlsoLinkURL": [
            "http://www.red-tercel.com",
            "http://www.citospin.com",
            "http://www.ncbi.nlm.nih.gov/mesh/68020370",
            "http://www.ncbi.nlm.nih.gov/mesh?term=cell%2C%20mesenchymal%20stem"
      ],
      "SeriousEventAssessmentType": [],
      "SeriousEventNotes": [],
      "SeriousEventOrganSystem": [],
      "SeriousEventSourceVocabulary": [],
      "SeriousEventStatsGroupId": [],
      "SeriousEventStatsNumAffected": [],
      "SeriousEventStatsNumAtRisk": [],
      "SeriousEventStatsNumEvents": [],
      "SeriousEventTerm": [],
      "StartDate": [
            "April 2012"
      ],
      "StartDateType": [],
      "StatusVerifiedDate": [
            "September 2015"
      ],
      "StdAge": [
            "Adult",
            "Older Adult"
      ],
      "StudyFirstPostDate": [
            "April 26, 2012"
      ],
      "StudyFirstPostDateType": [
            "Estimate"
      ],
      "StudyFirstSubmitDate": [
            "April 23, 2012"
      ],
      "StudyFirstSubmitQCDate": [
            "April 24, 2012"
      ],
      "StudyPopulation": [],
      "StudyType": [
            "Interventional"
      ],
      "SubmissionMCPReleaseN": [],
      "SubmissionReleaseDate": [],
      "SubmissionResetDate": [],
      "SubmissionUnreleaseDate": [],
      "TargetDuration": [],
      "UnpostedEventDate": [],
      "UnpostedEventType": [],
      "UnpostedResponsibleParty": [],
      "VersionHolder": [
            "October 10, 2022"
      ],
      "WhyStopped": []
}